Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 387.70
+4.40 (1.15%)
May 22, 2026, 4:59 PM CET
Novozymes Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 596.7 | 583.6 | 305.8 | 407.9 | 494.59 | 422.95 |
Depreciation & Amortization | - | 596.9 | 597.4 | 186.4 | - | - |
Stock-Based Compensation | - | 20.4 | 28.8 | 20.3 | - | - |
Other Adjustments | 590 | 581.9 | 422.7 | 160.5 | 122.37 | 206.7 |
Change in Receivables | - | -114.9 | -41.6 | -23.7 | -44.28 | -77.19 |
Changes in Inventories | - | 6.2 | 153.8 | 18.5 | -105.6 | -74.77 |
Changes in Accounts Payable | - | 164.7 | 158.8 | -17.1 | 71.65 | 69.66 |
Changes in Other Operating Activities | 110.6 | 56 | 271 | -23.9 | -1.21 | -1.08 |
Operating Cash Flow | 1,282 | 1,222 | 1,020 | 557.1 | 537.53 | 546.27 |
Operating Cash Flow Growth | 35.00% | 19.77% | 83.07% | 3.64% | -1.60% | -6.94% |
Capital Expenditures | -443.5 | -409.8 | -338.3 | -249.1 | -370.34 | -144.03 |
Sale of Property, Plant & Equipment | 2.8 | 19.7 | 0.8 | 0.5 | 3.76 | 16.68 |
Purchases of Intangible Assets | -65.2 | -61 | -21.5 | -26.7 | -17.44 | -22.73 |
Purchases of Investments | - | - | -0.4 | -1.5 | - | - |
Payments for Business Acquisitions | -1,520 | -4,559 | -114.5 | -68.1 | - | - |
Proceeds from Business Divestments | - | - | 433.5 | 35.4 | - | - |
Other Investing Activities | - | - | -12.9 | - | 25.49 | -219.34 |
Investing Cash Flow | -2,026 | -1,971 | -199.7 | -286.2 | -358.53 | -369.42 |
Short-Term Debt Issued | - | - | - | - | 25.9 | 42.09 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | 25.9 | 42.09 |
Long-Term Debt Issued | 3,418 | 1,717 | 134.5 | 442 | 287.15 | 288.33 |
Long-Term Debt Repaid | -1,934 | -504.6 | -539.8 | -334.7 | -231.06 | -186.39 |
Net Long-Term Debt Issued (Repaid) | 1,484 | 1,212 | -405.3 | 107.3 | 56.09 | 101.94 |
Issuance of Common Stock | 33.6 | 44 | 37.8 | 22.4 | 22.01 | 41.56 |
Repurchase of Common Stock | -69.1 | -99.9 | - | - | -67.09 | -201.72 |
Net Common Stock Issued (Repurchased) | -35.5 | -55.9 | 37.8 | 22.4 | -45.08 | -160.17 |
Common Dividends Paid | -667.8 | -402.7 | -249.8 | -383.2 | -204.63 | -197.15 |
Other Financing Activities | 49 | - | -85.9 | - | - | - |
Financing Cash Flow | 829.5 | 753.3 | -703.2 | -253.5 | -167.73 | -213.29 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -8.3 | -8.6 | 13.3 | -7.4 | -0.81 | 7.13 |
Net Cash Flow | 51.9 | -4.7 | 130.3 | 10 | 10.47 | -29.32 |
Free Cash Flow | 838.7 | 811.7 | 681.6 | 308 | 167.19 | 402.24 |
Free Cash Flow Growth | 3.33% | 19.09% | 121.30% | 84.22% | -58.44% | -16.20% |
FCF Margin | 19.97% | 19.52% | 17.78% | 12.82% | 7.10% | 20.01% |
Free Cash Flow Per Share | 1.80 | 1.74 | 1.48 | 1.11 | 0.60 | 1.44 |
Levered Free Cash Flow | 1,748 | 2,210 | 743.2 | 428 | 169.74 | 416.9 |
Unlevered Free Cash Flow | 313.08 | 1,055 | 1,210 | 329.62 | 89.64 | 281.68 |
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.